311 related articles for article (PubMed ID: 21892879)
21. A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry.
Tang H; Mayersohn M
J Pharm Sci; 2006 Aug; 95(8):1783-99. PubMed ID: 16795013
[TBL] [Abstract][Full Text] [Related]
22. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance.
Matsunaga N; Ufuk A; Morse BL; Bedwell DW; Bao J; Mohutsky MA; Hillgren KM; Hall SD; Houston JB; Galetin A
Drug Metab Dispos; 2019 Mar; 47(3):215-226. PubMed ID: 30593544
[TBL] [Abstract][Full Text] [Related]
23. A mathematical description of the functionality of correction factors used in allometry for predicting human drug clearance.
Tang H; Mayersohn M
Drug Metab Dispos; 2005 Sep; 33(9):1294-6. PubMed ID: 15919851
[TBL] [Abstract][Full Text] [Related]
24. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
[TBL] [Abstract][Full Text] [Related]
25. Preclinical pharmacokinetics and interspecies scaling of ragaglitazar, a novel biliary excreted PPAR dual activator.
Pavankuamr VV; Vinu CA; Mullangi R; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2007; 32(1):29-37. PubMed ID: 17479541
[TBL] [Abstract][Full Text] [Related]
26. Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches.
Mahmood I
Drug Metabol Drug Interact; 2002; 19(1):49-64. PubMed ID: 12222754
[TBL] [Abstract][Full Text] [Related]
27. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
[TBL] [Abstract][Full Text] [Related]
28. Interspecies allometric scaling. Part I: prediction of clearance in large animals.
Mahmood I; Martinez M; Hunter RP
J Vet Pharmacol Ther; 2006 Oct; 29(5):415-23. PubMed ID: 16958787
[TBL] [Abstract][Full Text] [Related]
29. Interspecies scaling of renally secreted drugs.
Mahmood I
Life Sci; 1998; 63(26):2365-71. PubMed ID: 9877226
[TBL] [Abstract][Full Text] [Related]
30. Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance.
Horiuchi K; Ohnishi S; Matsuzaki T; Funaki S; Watanabe A; Mizutare T; Matsumoto S; Nezasa KI; Hasegawa H
J Pharm Sci; 2018 May; 107(5):1443-1453. PubMed ID: 29331382
[TBL] [Abstract][Full Text] [Related]
31. Interspecies prediction of human drug clearance based on scaling data from one or two animal species.
Tang H; Hussain A; Leal M; Mayersohn M; Fluhler E
Drug Metab Dispos; 2007 Oct; 35(10):1886-93. PubMed ID: 17646280
[TBL] [Abstract][Full Text] [Related]
32. Predicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data.
Nakayama K; Kamimura H; Suemizu H; Yoneda N; Nishiwaki M; Iwamoto K; Mizunaga M; Negoro T; Ito S; Yamazaki H; Nomura Y
Drug Metab Pharmacokinet; 2020 Aug; 35(4):389-396. PubMed ID: 32690433
[TBL] [Abstract][Full Text] [Related]
33. An algorithm for evaluating potential tissue drug distribution in toxicology studies from readily available pharmacokinetic parameters.
Poulin P; Dambach DM; Hartley DH; Ford K; Theil FP; Harstad E; Halladay J; Choo E; Boggs J; Liederer BM; Dean B; Diaz D
J Pharm Sci; 2013 Oct; 102(10):3816-29. PubMed ID: 23878104
[TBL] [Abstract][Full Text] [Related]
34. Interspecies scaling and comparisons in drug development and toxicokinetics.
Ings RM
Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
[TBL] [Abstract][Full Text] [Related]
35. Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro-In Vivo Scaling of Hepatic Uptake Clearance.
De Bruyn T; Ufuk A; Cantrill C; Kosa RE; Bi YA; Niosi M; Modi S; Rodrigues AD; Tremaine LM; Varma MVS; Galetin A; Houston JB
Drug Metab Dispos; 2018 Jul; 46(7):989-1000. PubMed ID: 29720472
[TBL] [Abstract][Full Text] [Related]
36. Interspecies scaling: predicting oral clearance in humans.
Mahmood I
Am J Ther; 2002; 9(1):35-42. PubMed ID: 11782818
[TBL] [Abstract][Full Text] [Related]
37. Prediction of hepatic metabolic clearance: comparison and assessment of prediction models.
Zuegge J; Schneider G; Coassolo P; Lavé T
Clin Pharmacokinet; 2001; 40(7):553-63. PubMed ID: 11510631
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic Model for the Prediction of Small-Molecule Vitreal Clearance Combining Diffusion-Limited and Permeability-Limited Clearance.
Rimpelä AK; Cui Y; Sauer A
Mol Pharm; 2021 Jul; 18(7):2703-2713. PubMed ID: 34151575
[TBL] [Abstract][Full Text] [Related]
39. Interspecies scaling of therapeutic monoclonal antibodies: initial look.
Ling J; Zhou H; Jiao Q; Davis HM
J Clin Pharmacol; 2009 Dec; 49(12):1382-402. PubMed ID: 19837907
[TBL] [Abstract][Full Text] [Related]
40. Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.
Sanwald-Ducray P; Dow J
Xenobiotica; 1997 Feb; 27(2):189-201. PubMed ID: 9058532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
